{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:58:57Z","timestamp":1762869537708,"version":"3.38.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00880-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:02:49Z","timestamp":1741600969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of potential molecular subtypes and signatures of thyroid eye disease based on angiogenesis-related gene analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Zixuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"9","key":"880_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1503\/cmaj.121815","volume":"185","author":"MJ Belliveau","year":"2013","unstructured":"Belliveau MJ, Jordan DR. Thyroid eye disease. CMAJ. 2013;185(9):797.","journal-title":"CMAJ"},{"issue":"8","key":"880_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41433-021-01593-z","volume":"36","author":"S Ugradar","year":"2022","unstructured":"Ugradar S, Kang J, Kossler AL, Zimmerman E, Braun J, Harrison AR, Bose S, Cockerham K, Douglas RS. Teprotumumab for the treatment of chronic thyroid eye disease. Eye (Lond). 2022;36(8):1553\u201359.","journal-title":"Eye (Lond)"},{"issue":"Suppl_1","key":"880_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1210\/clinem\/dgac045","volume":"107","author":"L Girnita","year":"2022","unstructured":"Girnita L, Smith TJ, Janssen J. It takes two to Tango: IGF-I and TSH receptors in thyroid eye disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S1\u2013S12.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"880_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/cxo.12472","volume":"100","author":"DL Weiler","year":"2017","unstructured":"Weiler DL. Thyroid eye disease: a review. Clin Exp Optom. 2017;100(1):20\u201325.","journal-title":"Clin Exp Optom"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson E, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marino M, et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 2020;382:341\u201352.","journal-title":"N Engl J Med"},{"issue":"17","key":"880_CR6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s40265-022-01804-1","volume":"82","author":"T Nie","year":"2022","unstructured":"Nie T, Lamb YN. Teprotumumab: a review in thyroid eye disease. DRUGS. 2022;82(17):1663\u201370.","journal-title":"DRUGS"},{"issue":"2","key":"880_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ceo.13899","volume":"49","author":"AP Jain","year":"2021","unstructured":"Jain AP, Jaru-Ampornpan P, Douglas RS. Thyroid eye disease: redefining its management-A review. Clin Exp Ophthalmol. 2021;49(2):203\u201311.","journal-title":"Clin Exp Ophthalmol"},{"key":"880_CR8","first-page":"970386640","volume":"13","author":"CJ Men","year":"2021","unstructured":"Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol. 2021;13:970386640.","journal-title":"Ther Adv Ophthalmol"},{"key":"880_CR9","doi-asserted-by":"crossref","unstructured":"La Mendola D, Trincavelli ML, Martini C. Angiogenesis in Disease. Int J Mol Sci. 2022;23(18).","DOI":"10.3390\/ijms231810962"},{"key":"880_CR10","doi-asserted-by":"publisher","first-page":"393114839","DOI":"10.1177\/20503121211001641","volume":"9","author":"Y Ren","year":"2021","unstructured":"Ren Y, Luo H. Metformin: the next angiogenesis panacea? SAGE Open Med. 2021;9:393114839.","journal-title":"SAGE Open Med"},{"key":"880_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-030-36588-2_7","volume":"1230","author":"L Costa","year":"2020","unstructured":"Costa L, Reis RL, Silva-Correia J, Oliveira JM. Microfluidics for Angiogenesis Research. Adv Exp Med Biol. 2020;1230:97\u2013119.","journal-title":"Adv Exp Med Biol"},{"key":"880_CR12","doi-asserted-by":"crossref","unstructured":"Kretschmer M, Rudiger D, Zahler S. Mechanical aspects of Angiogenesis. Cancers (Basel). 2021;13(19).","DOI":"10.3390\/cancers13194987"},{"key":"880_CR13","doi-asserted-by":"publisher","first-page":"943158","DOI":"10.3389\/fphar.2022.943158","volume":"13","author":"L Trabalzini","year":"2022","unstructured":"Trabalzini L, Tundis R, Valacchi G, Evelson PA, Finetti F. Editorial: angiogenesis and nutraceuticals. Front Pharmacol. 2022;13:943158.","journal-title":"Front Pharmacol"},{"key":"880_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.dcmed.2021.06.003","volume":"4","author":"P Li","year":"2021","unstructured":"Li P, Yi N, Ding CS, et al. Research on classification diagnosis model of psoriasis based on deep residual network. Digit Chin Med 2021;4:92\u2013101.","journal-title":"Digit Chin Med"},{"key":"880_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.dcmed.2022.03.005","volume":"5","author":"CD Peng","year":"2022","unstructured":"Peng CD, Wang L, Jiang DM, et al. Establishing and validating a spotted tongue recognition and extraction model based on multiscale convolutional neural network. Digit Chin Med 2022;5:49\u201358.","journal-title":"Digit Chin Med"},{"key":"880_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.dcmed.2022.06.006","volume":"5","author":"XY Zhou","year":"2022","unstructured":"Zhou XY, Yang SW, Ou JT, et al. Screening influencing factors of blood stasis constitution in traditional Chinese medicine. Digit Chin Med 2022;5:169\u201377.","journal-title":"Digit Chin Med"},{"issue":"1","key":"880_CR17","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1038\/s41598-023-33277-x","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Liu P, Huang B, Deng S, Song Z, Huang X, Yang J, Cheng S. A novel Alzheimer\u2019s disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy. Sci Rep. 2023;13(1):6895.","journal-title":"Sci Rep"},{"issue":"7","key":"880_CR18","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/bioinformatics\/btz889","volume":"36","author":"S Su","year":"2020","unstructured":"Su S, Tian L, Dong X, Hickey PF, Freytag S, Ritchie ME. CellBench: r\/Bioconductor software for comparing single-cell RNA-seq analysis methods. Bioinformatics. 2020;36(7):2288\u201390.","journal-title":"Bioinformatics"},{"key":"880_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.11646\/zootaxa.3746.2.8","volume":"3746","author":"TR De Carvalho","year":"2013","unstructured":"De Carvalho TR, Giaretta AA, Teixeira BF, Martins LB. New bioacoustic and distributional data on Bokermannohyla sapiranga Brandao et al., 2012 (Anura: hylidae): revisiting its diagnosis in comparison with B. pseudopseudis (Miranda-Ribeiro, 1937). Zootaxa. 2013;3746:383\u201392.","journal-title":"Zootaxa"},{"issue":"D1","key":"880_CR20","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u2013D131.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"880_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/sms.13515","volume":"29","author":"D Mon-Lopez","year":"2019","unstructured":"Mon-Lopez D, Tejero-Gonzalez CM. Validity and reliability of the TargetScan ISSF Pistol & Rifle application for measuring shooting performance. Scand J Med Sci Sports. 2019;29(11):1707\u201312.","journal-title":"Scand J Med Sci Sports"},{"issue":"2","key":"880_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","volume":"51","author":"TD Hoang","year":"2022","unstructured":"Hoang TD, Stocker DJ, Chou EL, Burch HB. 2022 Update on clinical management of graves disease and thyroid eye disease. Endocrinol Metab Clin North Am. 2022;51(2):287\u2013304.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"880_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bjophthalmol-2020-316051","volume":"105","author":"JJ Khong","year":"2021","unstructured":"Khong JJ, McNab A. Medical treatment in thyroid eye disease in 2020. Br J Ophthalmol. 2021;105(3):299\u2013305.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"880_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eprac.2020.11.011","volume":"27","author":"MH Lee","year":"2021","unstructured":"Lee MH, Chin YH, Ng CH, Nistala K, Ow Z, Sundar G, Yang SP, Khoo CM. Risk factors of thyroid eye disease. Endocr Pract. 2021;27(3):245\u201353.","journal-title":"Endocr Pract"},{"key":"880_CR25","doi-asserted-by":"crossref","unstructured":"Rashad R, Pinto R, Li E, Sohrab M, Distefano AG. Thyroid eye disease. Life (Basel). 2022;12(12).","DOI":"10.3390\/life12122084"},{"issue":"4","key":"880_CR26","first-page":"343","volume":"119","author":"J Szelog","year":"2022","unstructured":"Szelog J, Swanson H, Sniegowski MC, Lyon DB. Thyroid eye disease. Mo Med. 2022;119(4):343\u201350.","journal-title":"Mo Med"},{"issue":"7","key":"880_CR27","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.4103\/ijo.IJO_3217_21","volume":"70","author":"CY Yu","year":"2022","unstructured":"Yu CY, Ford RL, Wester ST, Shriver EM. Update on thyroid eye disease: regional variations in prevalence, diagnosis, and management. Indian J Ophthalmol. 2022;70(7):2335\u201345.","journal-title":"Indian J Ophthalmol"},{"key":"880_CR28","doi-asserted-by":"crossref","unstructured":"Vega R, Carretero M, Bonilla LL. Anomalous Angiogenesis in Retina. Biomedicines. 2021;9(2).","DOI":"10.3390\/biomedicines9020224"},{"issue":"18","key":"880_CR29","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.cub.2023.07.040","volume":"33","author":"JH Liang","year":"2023","unstructured":"Liang JH, Akhanov V, Ho A, Tawfik M, D\u2019Souza SP, Cameron MA, Lang RA, Samuel MA. Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina. Curr Biol. 2023;33(18):3821\u201334.","journal-title":"Curr Biol"},{"issue":"10","key":"880_CR30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.oret.2022.05.007","volume":"6","author":"S Kitahata","year":"2022","unstructured":"Kitahata S, Inoue M, Yanagi Y, Tanaka S, Inoue T, Yamakawa T, Uchio E, Kadonosono K. Angiogenesis and Anastomosis on Graft Retina after Autologous Retinal Transplantation. Ophthalmol Retina. 2022;6(10):972\u201374.","journal-title":"Ophthalmol Retina"},{"key":"880_CR31","doi-asserted-by":"publisher","first-page":"25346","DOI":"10.1002\/anie.202108961","volume":"60","author":"L Chen","year":"2021","unstructured":"Chen L, Li N, Zhang M, Sun M, Bian J, Yang B, Li Z, Wang J, Li F, Shi X, et al. APEX2-based Proximity Labeling of Atox1 Identifies CRIP2 as a nuclear copper-binding protein that regulates autophagy activation. Angew Chem Int Ed Engl 2021;60:25346\u201355.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"880_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41419-023-06247-4","volume":"14","author":"L Shi","year":"2023","unstructured":"Shi L, Zha H, Pan Z, Wang J, Xia Y, Li H, Huang H, Yue R, Song Z, Zhu J. DUSP1 protects against ischemic acute kidney injury through stabilizing mtDNA via interaction with JNK. Cell Death Dis. 2023;14(11):724.","journal-title":"Cell Death Dis"},{"issue":"6","key":"880_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14728222.2020.1751821","volume":"24","author":"E Reeves","year":"2020","unstructured":"Reeves E, Islam Y, James E. ERAP1: a potential therapeutic target for a myriad of diseases. Expert Opin Ther Targets. 2020;24(6):535\u201344.","journal-title":"Expert Opin Ther Targets"},{"key":"880_CR34","doi-asserted-by":"publisher","first-page":"873871","DOI":"10.3389\/fimmu.2022.873871","volume":"13","author":"S Weng","year":"2022","unstructured":"Weng S, Liu Z, Ren X, Xu H, Ge X, Ren Y, Zhang Y, Dang Q, Liu L, Guo C, et al. SCG2: a prognostic marker that pinpoints chemotherapy and immunotherapy in colorectal cancer. Front Immunol. 2022;13:873871.","journal-title":"Front Immunol"},{"key":"880_CR35","doi-asserted-by":"publisher","first-page":"e1010902","DOI":"10.1371\/journal.pgen.1010902","volume":"19","author":"J Xu","year":"2023","unstructured":"Xu J, Xu W, Choi J, Brhane Y, Christiani DC, Kothari J, McKay J, Field JK, Davies M, Liu G, et al. Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. PLOS Genet 2023;19:e1010902.","journal-title":"PLOS GENET"},{"issue":"10","key":"880_CR36","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s00262-023-03485-5","volume":"72","author":"L Huang","year":"2023","unstructured":"Huang L, Lou N, Xie T, Tang L, Han X, Shi Y. Identification of an antigen-presenting cells\/T\/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing. Cancer Immunol Immunother. 2023;72(10):3259\u201377.","journal-title":"Cancer Immunol Immunother"},{"key":"880_CR37","doi-asserted-by":"publisher","first-page":"1158087","DOI":"10.3389\/fonc.2023.1158087","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhao Y, Yang J, Zhu Y, Li T, Liu X, Zhang P, Cheng J, Sun S, Wei C, et al. CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer. Front Oncol. 2023;13:1158087.","journal-title":"Front Oncol"},{"key":"880_CR38","doi-asserted-by":"publisher","first-page":"e2306365","DOI":"10.1002\/advs.202306365","volume":"11","author":"H Qu","year":"2024","unstructured":"Qu H, Liu X, Zhu J, Xiong X, Li L, He Q, Wang Y, Yang G, Zhang L, Yang Q, et al. Dock5 deficiency promotes proteinuric kidney diseases via modulating podocyte lipid metabolism. Adv Sci (Weinh) 2024;11:e2306365.","journal-title":"Adv Sci (Weinh)"},{"key":"880_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13062-023-00396-4","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Li G, Zheng S, She L, Lu S, Wang Y, Huang D, Zhang X, Sun L, Liu Y, et al. PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation. Biol Direct 2023;18:39.","journal-title":"Biol Direct"},{"key":"880_CR40","doi-asserted-by":"publisher","first-page":"e137654","DOI":"10.1371\/journal.pone.0137654","volume":"10","author":"JT Rosenbaum","year":"2015","unstructured":"Rosenbaum JT, Choi D, Wong A, Wilson DJ, Grossniklaus HE, Harrington CA, Dailey RA, Ng JD, Steele EA, Czyz CN, et al. The role of the immune response in the pathogenesis of thyroid eye disease: a reassessment. PLoS ONE 2015;10:e137654.","journal-title":"PLoS ONE"},{"key":"880_CR41","first-page":"1728423","volume":"2020","author":"R Nallu","year":"2020","unstructured":"Nallu R, Madhavan P, Chirch L, Luthra P. Thyroid eye disease due to immune reconstitution inflammatory syndrome as a consequence of antiretroviral therapy in the setting of AIDS. Case Rep Endocrinol. 2020;2020:1728423.","journal-title":"Case Rep Endocrinol"},{"issue":"9","key":"880_CR42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1089\/thy.2007.0407","volume":"18","author":"GM Lehmann","year":"2008","unstructured":"Lehmann GM, Feldon SE, Smith TJ, Phipps RP. Immune mechanisms in thyroid eye disease. Thyroid. 2008;18(9):959\u201365.","journal-title":"Thyroid"},{"key":"880_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/IOP.0000000000001161","volume":"35","author":"O Sagiv","year":"2019","unstructured":"Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, et al. Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients. Ophthalmic Plast Reconstr Surg 2019;35:50\u201352.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"880_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40123-020-00317-y","volume":"10","author":"C Chau","year":"2021","unstructured":"Chau C, Shih KC, Chow L, Lee V. Considerations for use of immune checkpoint inhibitors in cancer therapy for patients with co-existing thyroid eye disease. Ophthalmol Ther. 2021;10(1):5\u201312.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"880_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/tjo.tjo_51_21","volume":"12","author":"JS Yoon","year":"2022","unstructured":"Yoon JS, Kikkawa DO. Thyroid eye disease: from pathogenesis to targeted therapies. Taiwan J Ophthalmol. 2022;12(1):3\u201311.","journal-title":"Taiwan J Ophthalmol"},{"key":"880_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2022.02.015","volume":"240","author":"CM Sears","year":"2022","unstructured":"Sears CM, Azad AD, Amarikwa L, Pham BH, Men CJ, Kaplan DN, Liu J, Hoffman AR, Swanson A, Alyono J, et al. Hearing dysfunction after treatment with Teprotumumab for thyroid eye disease. Am J Ophthalmol. 2022;240:1\u201313.","journal-title":"Am J Ophthalmol"},{"key":"880_CR47","first-page":"7588084","volume":"2022","author":"H Liu","year":"2022","unstructured":"Liu H, Chen L, Lei X, Ren H, Li G, Deng Z. Identification of hub genes associated with nonspecific orbital inflammation by weighted gene coexpression network analysis. Dis Markers. 2022;2022:7588084.","journal-title":"Dis Markers"},{"issue":"1","key":"880_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40246-022-00412-0","volume":"16","author":"J Hu","year":"2022","unstructured":"Hu J, Zhou S, Guo W. Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis. Hum Genomics. 2022;16(1):38.","journal-title":"Hum Genomics"},{"key":"880_CR49","doi-asserted-by":"publisher","first-page":"858972","DOI":"10.3389\/fimmu.2022.858972","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Zhou Q. Gene biomarkers related to Th17 cells in Macular Edema of diabetic retinopathy: cutting-edge comprehensive bioinformatics analysis and in vivo validation. Front Immunol. 2022;13:858972.","journal-title":"Front Immunol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00880-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:38:51Z","timestamp":1741603131000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00880-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00880-9","relation":{},"ISSN":["2050-6511"],"issn-type":[{"type":"electronic","value":"2050-6511"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is not a clinical trial, hence the ethics approval and consent to participation are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participation"}},{"value":"All authors have read and approved this manuscript to be considered for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}